1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Assessing Concurrent Adherence to Combined Essential Medication and Clinical Outcomes in Patients With Acute Coronary Syndrome. A Population-Based, Real-World Study Using Group-Based Trajectory Models

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aim

          Adherence to multiple medications recommended for secondary prevention of cardiovascular conditions represents a challenge. We aimed to identify patterns of concurrent adherence to combined therapy and assess their impact on clinical outcomes in a cohort of patients with acute coronary syndrome (ACS).

          Methods

          Population-based retrospective cohort of all patients discharged after hospitalization for ACS (2009–2011), prescribed ≥3 therapeutic groups within the first month. We assessed monthly concurrent adherence (≥24 days of medication out of 30) to ≥3 medications during the first year, and patterns were identified through group-based trajectory models. A composite clinical outcome during the second year was constructed. The association between adherence patterns and traditional refill adherence metrics [e.g., the proportion of days covered (PDC)], and outcomes were assessed through a multivariable Cox proportional hazards model.

          Results

          Among 15,797 patients discharged alive, 12,057 (76.32%) initiated treatment with ≥3 therapeutic groups after discharge. We identified seven adherence trajectories to ≥3 medications: Adherent (52.94% of patients); Early Gap (6.64%); Middle Gap (5.67%); Late Decline (10.93%); Occasional Users (5.45%); Early Decline (8.79%); Non-Adherent (9.58%). Compared to the Adherent group, patients belonging to Early Gap (HR:1.30, 95%CI 1.07;1.60), Late decline (hazards ratio (HR): 1.31, 95% CI 1.1; 1.56), and Non-Adherent trajectories (HR: 1.36, 95% CI 1.14; 1.63) had a greater risk of adverse clinical outcomes, which was also different to the risk ascertained through concurrent PDC < 80 (HR: 1.13, 95% CI 1.01; 1.27).

          Conclusion

          Overall, seven adherence trajectories to ≥3 drugs were identified, with three distinct adherence patterns being at higher risk of adverse outcomes. The identification of patterns of concurrent adherence, a more comprehensive approach than traditional measurements, may be useful to target interventions to improve adherence to multiple medications.

          Graphical Abstract

          Our paper at a glance: assessing concurrent adherence to combined essential medication and clinical outcomes in acute coronary syndrome patients. A population-based, real-world study using group-based trajectory models.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: not found
          • Article: not found

          2020 International Society of Hypertension Global Hypertension Practice Guidelines

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Group-based trajectory modeling in clinical research.

              Group-based trajectory models are increasingly being applied in clinical research to map the developmental course of symptoms and assess heterogeneity in response to clinical interventions. In this review, we provide a nontechnical overview of group-based trajectory and growth mixture modeling alongside a sampling of how these models have been applied in clinical research. We discuss the challenges associated with the application of both types of group-based models and propose a set of preliminary guidelines for applied researchers to follow when reporting model results. Future directions in group-based modeling applications are discussed, including the use of trajectory models to facilitate causal inference when random assignment to treatment condition is not possible.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Cardiovasc Med
                Front Cardiovasc Med
                Front. Cardiovasc. Med.
                Frontiers in Cardiovascular Medicine
                Frontiers Media S.A.
                2297-055X
                25 May 2022
                2022
                : 9
                : 863876
                Affiliations
                [1] 1Health Services Research Unit, The Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO) , Valencia, Spain
                [2] 2Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) , Valencia, Spain
                Author notes

                Edited by: Liesl Joanna Zühlke, South African Medical Research Council, South Africa

                Reviewed by: Chien-Yi Hsu, Taipei Medical University Hospital, Taiwan; Susan Abughosh, University of Houston, United States; Eelko Hak, University of Groningen, Netherlands

                *Correspondence: Clara L. Rodríguez-Bernal rodriguez_claber@ 123456gva.es

                This article was submitted to Cardiovascular Epidemiology and Prevention, a section of the journal Frontiers in Cardiovascular Medicine

                Article
                10.3389/fcvm.2022.863876
                9174582
                35694663
                2fe10cfe-f062-4ef5-90ec-ea6a7355ce1a
                Copyright © 2022 Rodríguez-Bernal, Sánchez-Saez, Bejarano-Quisoboni, Hurtado, García-Sempere, Peiró and Sanfélix-Gimeno.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 27 January 2022
                : 21 March 2022
                Page count
                Figures: 5, Tables: 2, Equations: 0, References: 29, Pages: 12, Words: 6457
                Funding
                Funded by: Instituto de Salud Carlos III, doi 10.13039/501100004587;
                Categories
                Cardiovascular Medicine
                Original Research

                concurrent adherence,concomitant medications,acute coronary syndrome,group-based trajectory models,clinical outcomes,real-world data,population-based cohort

                Comments

                Comment on this article